La cadena de opciones muestra datos clave de las opciones de acciones de ProPhase Labs a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para ProPhase Labs..

ProPhase Labs (NASDAQ:PRPH) Bolsa, Cadena de Opciones

ProPhase Labs

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

ProPhase Labs Inc

Press Releases

ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement

ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025

ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment

ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025

Small Cap

Opinion

Biotech Stocks Rally as Oncology Market Targets $866B by 2034

ProPhase Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of Shareholders

ProPhase Labs Inc. to Participate in Renmark's Virtual Non-Deal Roadshow Series on Thursday, September 4, 2025

ProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In Favor

ProPhase Continues its Exploration of a Crypto Treasury Strategy

PROPHASE LABS, INC. ANNOUNCES COMPLETION OF IMPORTANT NEXT STEP FOR CROWN MEDICAL COLLECTIONS $50 MILLION A/R INITIATIVE

IOBT

OLMA

ONCY

PDSB

PRPH

TSX:ONC

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Hldgs

Athira Pharma

Aytu BioPharma

Cingulate

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical

Cocrystal Pharma

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals

Curanex Pharmaceuticals Inc - Common Stock

Curanex Pharmaceuticals

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics

Dare Bioscience

Gelteq

Hoth Therapeutics

Iterum Therapeutics

Incannex Healthcare

Lexaria Bioscience

Lipocine

Lyra Therapeutics

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

Processa Pharmaceuticals, Inc. - Common Stock

Processa Pharmaceuticals

Pulmatrix

PolyPid

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Hldgs

SenesTech

Traws Pharma

TherapeuticsMD

HC Wainwright & Co.

Comments

ProPhase Labs

ProPhase Labs (PRPH) Opciones

ProPhase Labs (NASDAQ:PRPH) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL